Quantcast

Monday 3/11 Insider Buying Report: MDCO, STBA


Shutterstock photo

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

On Wednesday, Medicines ( MDCO )'s Director, Alexander J. Denner, made a $6.18M purchase of MDCO, buying 248,100 shares at a cost of $24.91 a piece. So far Denner is in the green, up about 3.0% on their purchase based on today's trading high of $25.65. Medicines is trading up about 0.3% on the day Monday. Before this latest buy, Denner bought MDCO at 4 other times during the past year, for a total cost of $32.84M at an average of $22.40 per share.

And on Thursday, Director James Thomas Gibson purchased $466,691 worth of S&T Bancorp ( STBA ), purchasing 12,000 shares at a cost of $38.89 a piece. S&T Bancorp is trading up about 0.1% on the day Monday. Gibson was up about 1.6% on the buy at the high point of today's trading session, with STBA trading as high as $39.51 in trading on Monday.

Monday 3/11 Insider Buying Report: MDCO, STBA VIDEO: Monday 3/11 Insider Buying Report: MDCO, STBA

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.





This article appears in: Investing , Investing Ideas
Referenced Symbols: MDCO , STBA




More from BNK Invest

Subscribe






BNK Invest
Contributor:

BNK Invest

Market News, Investing












Research Brokers before you trade

Want to trade FX?